While the Huntington’s Disease Society of America (HDSA) is pleased a U.S. House of Representatives subcommittee recently held a…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
The Cleveland Team Hope Walk & 5K Run is on tap for Aug. 15 to raise funds to help the…
At its first virtual investor event, biotech company Centogene set a bold mission: to cure 100 rare diseases…
To help patient advocacy leaders and their partners better understand how global health statistics codes — known as ICD codes…
Those who wish to gain practical tools for living optimally with rare diseases are encouraged to attend the annual…
U.S. lawmakers have again introduced legislation that would speed up the process for Huntington’s disease (HD) patients to get…
Activities are underway worldwide to mark Huntington’s Disease Awareness Month, set aside each year to call attention to the neurodegenerative…
An alliance of Huntington’s disease (HD) organizations in the U.K. is calling for patient contributions to a project that…
With some recent additions, the Huntington’s Disease Society of America (HDSA) has expanded its Centers of Excellence program…
Rare Disease Day at NIH, organized by the National Institutes of Health (NIH) and taking place on March 1,…